---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-040784"
form_type: "8-K"
ticker: "GMED"
cik: "0001237831"
company_name: "GLOBUS MEDICAL INC"
filed_at: "2026-06-04T20:11:31+00:00"
generated_at: "2026-06-04T20:43:17.880909+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Globus Medical shareholders approve 1M share increase to equity plan, re-elect directors

## Summary
- Stockholders approved amendment to 2021 Equity Incentive Plan, increasing authorized shares by 1,000,000 to 12,000,000.
- Keith Pfeil and Robert A. Douglas re-elected as Class II directors with substantial majority support.
- Deloitte & Touche LLP ratified as independent auditor for fiscal year ending December 31, 2026.
- Non-binding advisory vote on 2025 executive compensation passed with 316M for vs. 5.2M against.
- No other matters were submitted to stockholders at the June 3, 2026 Annual Meeting.

## SEC filing metadata
- accession: 0001628280-26-040784
- form_type: 8-K
- ticker: GMED
- cik: 0001237831
- company_name: GLOBUS MEDICAL INC
- filed_at: 2026-06-04T20:11:31+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1237831/000162828026040784/0001628280-26-040784-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1237831/000162828026040784/gmed-20260603.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-040784
- JSON: https://secwatch.observer/filing/0001628280-26-040784.json
- Plain text: https://secwatch.observer/filing/0001628280-26-040784.txt

## Key facts
- Shareholder Votes
  GLOBUS MEDICAL INC shareholders approved Approval of 2021 Equity Incentive Plan Amendment.
  - Proposal: equity plan
  - Outcome: passed
  source text: The Company’s stockholders approved the 2021 Equity Incentive Plan Amendment.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1237831/000162828026040784/0001628280-26-040784-index.htm
- Shareholder Votes
  GLOBUS MEDICAL INC shareholders approved Approval, on a non-binding, advisory basis, of the 2025 compensation of the Company’s named executive officers.
  - Proposal: say on pay
  - Outcome: passed
  source text: The Company’s stockholders approved, on a non-binding, advisory basis the 2025 compensation of the Company’s named executive officers, as described in the Proxy Statement.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1237831/000162828026040784/0001628280-26-040784-index.htm
- Shareholder Votes
  GLOBUS MEDICAL INC shareholders approved Election of two Class II directors to serve until the 2029 Annual Meeting of Stockholders.
  - Proposal: director election
  - Outcome: passed
  source text: Each of the director nominees listed below were elected by the Company’s stockholders at the Annual Meeting to serve a three-year term on the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1237831/000162828026040784/0001628280-26-040784-index.htm
- Shareholder Votes
  GLOBUS MEDICAL INC shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 at the 2026-12-31 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-12-31
  source text: The Company’s stockholders approved the ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1237831/000162828026040784/0001628280-26-040784-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.